Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors

Key facts

Sponsor

Children's Oncology Group

Principal Investigator

Anne Frazier, MD

Children's Oncology Group

Intervention

conventional surgery(procedure)

Enrollment

302 enrolled

Eligibility

21 years · All sexes

Timeline

2003 – 2021

Study locations (30)

• University of Alabama at Birmingham, Birmingham, Alabama, United States
• Phoenix Childrens Hospital, Phoenix, Arizona, United States
• University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
• Southern California Permanente Medical Group, Downey, California, United States
• Loma Linda University Medical Center, Loma Linda, California, United States
• Miller Children's Hospital, Long Beach, California, United States
• Children's Hospital Los Angeles, Los Angeles, California, United States
• Children's Hospital Central California, Madera, California, United States
• Children's Hospital and Research Center at Oakland, Oakland, California, United States
• Kaiser Permanente-Oakland, Oakland, California, United States
• Childrens Hospital of Orange County, Orange, California, United States
• Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States
• Sutter General Hospital, Sacramento, California, United States
• Rady Children's Hospital - San Diego, San Diego, California, United States
• University of California San Francisco Medical Center-Parnassus, San Francisco, California, United States
• +15 more locations on ClinicalTrials.gov

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Extragonadal germ cell tumor

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT06418789
  High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors
  N.N. Petrov National Medical Research Center of Oncology
• RECRUITINGPHASE3NCT03067181
  Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
  Children's Oncology Group
• ACTIVE NOT RECRUITINGPHASE3NCT02375204
  Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
  Alliance for Clinical Trials in Oncology

See all trials for Extragonadal germ cell tumor →